SCHEMBL23015759

SCHEMBL23015759

CC(C)c1cncc(/C=C/C(N)=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.42
KDM4E B2RXH2 2/20 0.40
MAPK1 P28482 2/20 0.40
PTGS2 P35354 3/20 0.39
RAF1 P04049 1/20 0.38
PKMYT1 Q99640 1/20 0.38
CCNC P24863 2/20 0.36
CDK8 P49336 2/20 0.36
MET P08581 2/20 0.35
KDR P35968 2/20 0.35
AURKA O14965 1/20 0.35
ABL1 P00519 1/20 0.35
LCK P06239 1/20 0.35
FYN P06241 1/20 0.35
YES1 P07947 1/20 0.35
FGFR2 P21802 1/20 0.35
EPHA2 P29317 1/20 0.35
LTK P29376 1/20 0.35
AXL P30530 1/20 0.35
FLT3 P36888 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31458404 0.78 DYRK1A (0.44) DYRK1AKDM4EMAPK1PTGS2RAF1
SCHEMBL27497376 0.76 PELI1 (0.46) DYRK1AKDM4EMAPK1RAF1PKMYT1
SCHEMBL8247342 0.76 RAB9A (0.51) PTGS2CCNCCDK8NPC1RAB9A
SCHEMBL18650817 0.75 RXRA (0.50) KDM4EMAPK1SMN1; SMN2EGFRPELI1
SCHEMBL30589032 0.75 HCAR2 (0.43) DYRK1AKDM4EMAPK1RAF1PKMYT1
SCHEMBL23015760 0.74 PTGS2 (0.51) DYRK1AKDM4EPTGS2RAF1PKMYT1
SCHEMBL1381805 0.74 KDM4E (0.70) KDM4EMAPK1PTGS2NPC1RAB9A
SCHEMBL12894656 0.74 KDM4E (0.70) KDM4EMAPK1PTGS2NPC1RAB9A
SCHEMBL19262996 0.73 TYR (0.48) PTGS2AKT1ALDH1A1
SCHEMBL23015745 0.73 MET (0.37) DYRK1AKDM4EMAPK1PTGS2CCNC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10927106-B2 Benzothiazole derivatives as DYRK1 inhibitors PHARMASUM THERAPEUTICS AS (NO) 2021-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10927106-B2 Benzothiazole derivatives as DYRK1 inhibitors DYRK1A, DYRK1B, PDK2 DYRK1A 1/4885KDM4E 984/4885MAPK1 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.